118 related articles for article (PubMed ID: 38156906)
1. Prognostic Role of Mitochondrial Transcription Termination Factor 3 in Thyroid Carcinoma.
Sun MT; Zhao HY; Ruan HJ; Yu LH; Guan ML; Fan JJ; Feng CZ; Lou YY
Genet Test Mol Biomarkers; 2023 Dec; 27(12):362-369. PubMed ID: 38156906
[No Abstract] [Full Text] [Related]
2. Expression of
Wang WS; Zi JJ; Sun MT; Mei W; Li SF; Yang N; Fei ZY; Zhang RP; Yu M; Xiong W
Transl Cancer Res; 2020 Jan; 9(1):173-186. PubMed ID: 35117171
[TBL] [Abstract][Full Text] [Related]
3. A high expression of MTERF3 correlates with tumor progression and predicts poor outcomes in patients with brain glioma.
Zi J; Wang W; Sun M; Mei W; Li S; Li B; Xiao Y; Fei Z; Zhang R; Yu M; Xiong W
Int J Clin Exp Pathol; 2019; 12(5):1909-1920. PubMed ID: 31934014
[TBL] [Abstract][Full Text] [Related]
4. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
[TBL] [Abstract][Full Text] [Related]
6. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
[TBL] [Abstract][Full Text] [Related]
7. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of prognostic m6A-related lncRNA and mRNA model in thyroid cancer.
Zhu Y; Yu T; Huang J; Ma X; Shen T; Li A; Yue R
Am J Cancer Res; 2022; 12(7):3259-3279. PubMed ID: 35968348
[TBL] [Abstract][Full Text] [Related]
10. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer.
Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y
Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322
[TBL] [Abstract][Full Text] [Related]
11. Identification of m6A-related lncRNAs for thyroid cancer recurrence.
Wang X; Su D; Wei Y; Liu S; Gao S; Tian H; Wei W
Gland Surg; 2023 Jan; 12(1):39-53. PubMed ID: 36761480
[TBL] [Abstract][Full Text] [Related]
12. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
[TBL] [Abstract][Full Text] [Related]
14. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
15. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Indicators for Survival in Patients with Thyroid Cancer Based on Expression of FAM3 Members.
Ma Y; Shi J; Liu Y; Cui W; Pan R; Qiu H; Han F; Hou N; Sun X
Crit Rev Eukaryot Gene Expr; 2023; 33(4):39-52. PubMed ID: 37183945
[TBL] [Abstract][Full Text] [Related]
17. NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma.
Gao Y; Wang Y; Guo R
Eur J Med Res; 2022 Nov; 27(1):235. PubMed ID: 36348408
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
Fu X; Zhou X; Ji F; He Q; Qiu X
Front Genet; 2023; 14():1215984. PubMed ID: 37560385
[No Abstract] [Full Text] [Related]
19. Diagnosis and Prognosis of Thyroid Cancer by Immune-related Genes.
Li J; Li Z; Zhao P
Am J Clin Oncol; 2024 Jan; 47(1):1-10. PubMed ID: 37779238
[TBL] [Abstract][Full Text] [Related]
20. YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration.
Zhang Y; Chen Y; Chen R; Zhou H; Lin Y; Li B; Song H; Zhou G; Dong M; Xu H
BMC Cancer; 2023 Sep; 23(1):882. PubMed ID: 37726690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
